Moderna’s coronavirus booster shot works to fight variant
Moderna has released data from the clinical trial of their new coronavirus vaccine that Its booster doses can help give better protection from the new South African variant. Moderna began developing and testing a new booster shot earlier this year after research, done in Petri dishes, suggested the B.1.351 variant was able to partially reduce the effectiveness of the leading vaccines.
Experts say that the current leading shots, Pfizer, Moderna, Johnson & Johnson, and Astra Zeneca, still protect against the new variants but are not clear how long that protection will last since we are in uncharted territory.
These findings could support a rollout of variant-specific booster doses by the end of 2021. Researchers have now begun to research multiple variant strains to boost the efficacy and protection of this new third shot.
For our source and more information on the Moderna clinical testing, please visit the National Institute of Health